U.S. Obesity Rate Drops As GLP-1 Usage Grows
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"U.S. Obesity Rate Drops As GLP-1 Usage Grows" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Hill, The Washington Post, Gallup News and The New York Times. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 44d ago.
Quick answers
Why is "U.S. Obesity Rate Drops As GLP-1 Usage Grows" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- GLP-1 use reaches record high as access appears easier The Hill · 45d ago
- Americans are taking GLP-1 drugs in record numbers The Washington Post · 45d ago
- In U.S., GLP-1 Usage Reaches New High Gallup News · 45d ago
- More Americans Than Ever Are Taking Weight-Loss Drugs The New York Times · 45d ago
- U.S. Obesity Rate Drops As GLP-1 Usage Grows Forbes · 45d ago
Topics
Related trends
How GLP-1 weight loss drugs are reshaping the healthcare industry
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Wegovy and Zepbound are changing how Americans get health care
GLP-1 medications like Wegovy and Zepbound are actively reshaping American healthcare while sparking critical industry debates.
Researchers looking into whether GLP-1 drugs can help slow aging
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Could GLP-1s help with alcohol use disorder? A Philly VA doctor is leading a national trial to find out.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
‘GTA VI’ Leaker Drops Even More New Footage, Reveals Motivations
2 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
Researchers find new benefits, risks in GLP-1 weight loss drugs
Recent reporting examines the expanding medical landscape surrounding GLP-1 weight loss medications.